Before You Use Lyxumia

Similar documents
Humulin (HU-mu-lin) R

N HUMAN Novo Nordisk Patient Information for Novolin N

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets

Medication Guide. SYMLIN (SĬM-lĭn) (pramlintide acetate) injection

TdaP-Booster (tee-dee-ay-pee boo-ster)

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and Clotrimazole 1% w/w

Package Leaflet: Information for the user

New Zealand Consumer Medicine Information

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

Galvumet Vildagliptin/Metformin hydrochloride Consumer Medicine Information

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

There is no information on the use of this medicine in those below 12 years of age.

Salamol CFC-Free Inhaler

IMIGRAN injection is also used for treatment of cluster headache. Before you use your IMIGRAN injection. When you must not use it

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

There is no information on the use of this medicine in those below 12 years of age.

Zomig Nasal Spray. Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION

New Zealand Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

New Zealand Consumer Medicine Information

APO-Metformin 500/850/1000 Contains the active ingredient metformin (met-for-min) hydrochloride

CONSUMER MEDICINE INFORMATION ARROW - ROXITHROMYCIN

UBISTESIN 1:200,000 and UBISTESIN FORTE 1:100,000

NEW ZEALAND CONSUMER MEDICINE INFORMATION Arrow - Diazepam

YOUR GUIDE TO THE LANTUS SOLOSTAR INSULIN PEN

Package leaflet: Information for the user Humalog 200 units/ml, solution for injection in pre-filled pen insulin lispro

isophane human insulin (prb) A Guide to Starting Humulin I

used to treat inflammation, corneal injury and bacterial infections in the external part of the eye.

This leaflet answers some common questions about ARROW - MELOXICAM.

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

FLIXONASE ALLERGY Non Drowsy Nasal Spray 24 hour Effective Relief and Prevention Available in 60 & 150 sprays

Filgrastim 300 mcg in 0.5 ml and 480 mcg in 0.5 ml (prefilled syringes) and 300 mcg in 1 ml (vials) solution for injection

A Guide to Starting. Humalog Mix25

MEDICATION GUIDE STELARA

XARELTO (Za REL toe) rivaroxaban

XARELTO (Za-REL-toe) rivaroxaban

Starting insulin treatment for people with type 2 diabetes. What you need to know

Guidance for self administration of insulin injections

Medication Guide Rebif (Re-bif) Interferon beta-1a (in-ter-feer-on beta-one-â)

Do not take Neulasta if you have had a serious allergic reaction to human G-CSFs such as pegfilgrastim or filgrastim products.

Starting insulin for people with type 2 diabetes

A patient guide to the use of insulin for diabetes

DULCOLAX Tablets and Suppositories Bisacodyl

HOW TO USE YOUR LANTUS SOLOSTAR PEN

Human Normal Immunoglobulin Solution for Intravenous Infusion.

PATIENT INFORMATION LEAFLET. Calcium Sandoz Syrup calcium glubionate and calcium lactobionate

EpiPen Adrenaline (Epinephrine) 300 µg/0.3 ml Auto-Injector

Do not use Tresiba if you are allergic to insulin degludec or any of the other ingredients of this medicine (listed in section 6).

New Zealand Consumer Medicine Information. 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine

NEW ZEALAND CONSUMER MEDICINE INFORMATION. other allergens, possibly unidentified.

New Zealand Consumer Medicine Information

human insulin (prb) 30% soluble insulin 70% isophane insulin A Guide to Starting Humulin M3

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

Rubifen SR 20 mg slow release tablets

Share the important information in this Medication Guide with members of your household.

Intestinal Permeability Leaky Gut Syndrome Protocol Dr. Kurt Woeller, D.O.

MALARONE Tablets (250/100) MALARONE Junior Tablets (62.5/25) MALARONE (Atovaquone and Proguanil Hydrochloride)

Testosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.

Losec. Omeprazole 10 mg, 20 mg and 40 mg capsules. CONSUMER MEDICINE INFORMATION

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules

MEDICATION GUIDE REBIF interferon beta-1a Injection for subcutaneous use

For the Patient: Dasatinib Other names: SPRYCEL

Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules

The safe use of insulin and you

HUMULIN R REGULAR INSULIN HUMAN INJECTION, USP (rdna ORIGIN) 100 UNITS PER ML (U-100)

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution

Diabex contains the active ingredient metformin hydrochloride

IMPORTANT: PLEASE READ

Department of Health Commencing insulin therapy

BROCKTON AREA MULTI-SERVICES, INC. MEDICAL PROCEDURE GUIDE. Date(s) Reviewed/Revised:

NovoRapid is a modern insulin (insulin analogue) with a rapid acting effect. Modern insulin products are improved versions of human insulin.

1 What Anapen is and what it is used for?

MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium)

Epipen Junior 150 micrograms solution for injection in pre-filled pen

SERETIDE Fluticasone propionate/salmeterol xinafoate Consumer Medicine Information

PIAX PLUS ASPIRIN 75/100 Film-Coated Tablets contains the active ingredients clopidogrel and aspirin

CONSUMER MEDICINE INFORMATION

Insulin Safety. The safe use of insulin and you. Patient Information Booklet

NovoRapid is a modern insulin (insulin analogue) with a rapid acting effect. Modern insulin products are improved versions of human insulin.

University College Hospital. Contrast agent for radiotherapy CT (computed tomography) scans. Radiotherapy Department Patient information series

Before you use Enbrel. When you must not use it

Patient Medication Guide Brochure

Protaphane InnoLet Mixtard 30/70 InnoLet

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE)

MEDICATION GUIDE. These serious side effects are described below:

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including:

Information for Starting Insulin Basal-Bolus Regime

Package leaflet: Information for the user. Insulatard 100 international units/ml suspension for injection in vial human insulin

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

Medication Guide. Serious loss of body fluid (dehydration) and changes in blood salts (electrolytes) in your blood.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

A list of all medications you are taking also include any vitamins, supplements, over-the-counter medicines, or herbal products

Package leaflet: Information for the patient

What Codeine Phosphate Tablets are used for

Understanding Diabetes

Package leaflet : information for the user. Dilute Adrenaline/Epinephrine Injection 1:10,000 adrenaline (epinephrine) (as acid tartrate) 0.

Transcription:

LYXUMIA lixisenatide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take the place of talking to your doctor or All medicines have risks and benefits. Your doctor has weighed the risks of you taking Lyxumia against the benefits they expect it will have for you. If you have any concerns about taking this medicine, ask your doctor or Keep this leaflet with the medicine. You may need to read it again. What Lyxumia Is Used For Lyxumia contains the active substance lixisenatide. Lyxumia is a medicine used to control the blood sugar level when it is too high in adult patients with type 2 diabetes mellitus. Lyxumia is used with other antidiabetic medicines for diabetes when they are not enough to control your blood sugar levels. Your doctor will prescribe the best combination to manage your type 2 diabetes mellitus. It is also important to control your diet and exercise while using Check with your doctor or healthcare professional if you are not sure whether your antidiabetic medicines contain a sulfonylurea or basal insulin. Diabetes mellitus is a condition in which your pancreas does not produce enough insulin to control your blood sugar (glucose) level. Lyxumia helps to control your blood sugar levels only when it is too high. Lyxumia is not a substitute for insulin in patients who require insulin treatments for their diabetes. In some cases it may be used as well as insulin. Your doctor, however, may have prescribed Lyxumia for another purpose. Ask your doctor if you have any questions about why it has been prescribed for you. This medicine is only available with a doctor's prescription. Before You Use Lyxumia When you must not use it Do not use Lyxumia if : you have type 1 diabetes or diabetic ketoacidosis (often caused by very high blood glucose levels). you are allergic to lixisenatide or meta-cresol or any of the ingredients listed at the end of this leaflet. You must not become pregnant while using It is not known if Lyxumia increases the risk of birth defects in humans. Do not use it if you are breastfeeding. Lyxumia may pass into breast milk and therefore there is a possibility that the breastfed baby may be affected. Do not give Lyxumia to a child or adolescent. Lyxumia has not been studied for use in children or adolescents under 18 years old. Do not use it after the expiry date (EXP) printed on the pack. If you use it after the expiry date has passed, it may not work as well. Do not use it if the packaging is torn or shows signs of tampering or if the pen appears damaged. Return the product to your pharmacist if it has expired or is damaged. Do not use Lyxumia if you see solid particles or if the solution is cloudy or coloured. Talk to your doctor if you are not sure if you should start using Before you start to use it Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes. Tell your doctor if you are also taking a sulfonylurea (such as glimepiride or glibenclamide). Your doctor may tell you to test your blood sugar levels. This will help your doctor to decide if the dose of the sulfonylurea needs to be changed. Tell your doctor if you have or have had any of the following medical conditions: kidney problems pancreatitis a history of persistent, severe abdominal pain. Tell your doctor if you have severe problems with your stomach or food digestion. Lyxumia slows stomach emptying so food passes more slowly through your stomach. lyxumia-ccdsv1-cmiv2-13mar14 Page 1

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if Lyxumia may harm your unborn child. Lyxumia should not be used during pregnancy. Tell your doctor if you are breastfeeding or planning to breastfeed. Lyxumia may pass into breast milk and therefore there is a possibility that this may affect your baby. If you have not told your doctor about any of the above, tell them before you use Taking other medicines you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food shop. you are taking a sulfonylurea (such as glimepiride or glibenclamide). This is because using Lyxumia at the same time may cause your blood sugar level to become too low (hypoglycaemia or a hypo ). When you first start using these medicines together, your doctor may tell you to lower the dose of the sulfonylurea. If you are not sure if the medicines you are taking contain a sulfonylurea, ask your doctor, diabetes educator/nurse or If you are taking a sulfonylurea as well as Lyxumia your doctor may ask you to test your blood sugar levels to begin with. This will help your doctor to decide if the dose of the sulfonylurea needs to be changed. Some medicines maybe affected by Lyxumia or may affect how it works. You may need different amounts of your medicines or you may need to take your medicines at different times. This includes: Medicines that need to pass through the stomach quickly such as antibiotics or stomach resistant tablets or capsules. Lyxumia slows stomach emptying and can affect these medicines Some medicines may need to be taken an hour before or 11 hours after your Lyxumia dose. Your doctor and pharmacist have more information on how to manage your other medicines while using How To Use Lyxumia How much to use Carefully follow all the directions given to you by your doctor or health care professional. They may differ from the information contained in this leaflet. Micrograms once a day for the first 14 days injected using the green pen. The dose from then onwards will be 20 micrograms once a day -using the purple pen. Make sure you are using the correct injection pen. Always check the label on the pen before each injection to make sure you are using the right medicine. Ask your doctor or pharmacist if you are unsure of the correct dose for you. They will tell you exactly how much to use. Follow the instructions they give you. These directions may differ from the information contained in this leaflet. If you take the wrong dose, Lyxumia may not work as well or you may experience side effects. Too much or too little Lyxumia can cause serious effects. It is very important that you manage your diabetes carefully. How to use it Before you use the injector pen for the first time, your doctor or nurse will show you how to inject Your doctor will tell you how much Lyxumia you will need to use each day. Read carefully the "Lyxumia pen Instructions for Use" provided in the carton. You must use the pen as described in these Instructions for Use. You must activate your LXYUMIA Pen before you use it for the first time. This will make sure that it is working correctly and that the dose for your first injection is correct. Carefully follow the instructions provided with your Lyxumia pen for attaching a needle. Always use a new needle for each injection. Carefully dispose of the needles after each use. Your Lyxumia pen is pre-filled and ready to use. Once all the medicine is used you cannot replace the cartridge. You will need to use a new pen. Injecting a dose Do not use Lyxumia if it is not clear and colourless or if it contains particles. lyxumia-ccdsv1-cmiv2-13mar14 Page 2

Lyxumia should be injected under the skin (subcutaneously) of your stomach area (abdomen), upper leg (thigh) or the back of your upper arm. Be careful not to inject it into a muscle or vein. To reduce the chance of local skin reaction, change the injection site within each particular area you are using so that the same site is not used more often than once a month. Read the instructions for use leaflet before beginning Lyxumia therapy. Read the instruction leaflet each time you get a new pen in case something has changed. Refer to the instruction leaflet each time you use this medicine. After injecting Using the outer needle cap, unscrew the needle and dispose of it safely into a sharps container. Do not share needles or injection devices. Do not reuse needles. Do not attempt to replace the cartridge in your Lyxumia pen. The cartridge in your Lyxumia pen cannot be removed or replaced. Empty pens must not be reused and must be properly discarded Ask your pharmacist how to discard the pen. When to use it Lyxumia should be injected once a day. Lyxumia should be injected within the hour before your first meal of the day or before your evening meal. If you are not sure when to use it, ask your doctor or How long to use it Continue using your medicine for as long as your doctor or pharmacist tells you. The medicine helps control your condition, but it does not cure it. Therefore, you must use it every day. Ask your doctor or pharmacist if you are not sure how long to use the medicine for. If you miss a dose Lyxumia should be used at approximately the same time each day. If you miss taking your dose at the regular scheduled time, your blood sugar levels may become high (hyperglycaemia). If you miss a dose of Lyxumia, you can inject the dose within the hour before your next meal. If you have missed a dose and are not sure what you should do, contact your doctor or healthcare professional for specific advice. Do NOT use a second dose of Lyxumia on the same day to make up for a dose you ve missed. The risk of hyperglycaemia is increased if you: miss doses of Lyxumia have uncontrolled diabetes exercise less than usual eat more carbohydrates than usual are ill or stressed High blood sugar levels over a period of time can lead to too much acid in the blood (diabetic ketoacidosis). If you are not sure what to do, ask your doctor or If you use too much (overdose) Your Lyxumia pen delivers a set dose of your medicine. If you accidentally inject a second dose on the same day, you may feel sick or be sick. Immediately telephone your doctor or the Poisons Information Centre (telephone Australia 13 11 26 or New Zealand 0800 POISON or 0800 764766), or go to Accident and Emergency at your nearest hospital, if you think you or anyone else may have used too much Do this even if there are no signs of discomfort or poisoning. While You Are Using Lyxumia Things you must do Tell all the doctors, dentists and pharmacists who are treating you that you are using Lyxumia Make sure all friends, relatives workmates or carers know that you have diabetes If you are about to be started on any new medicine, tell your doctor and pharmacist that you are using If you plan to travel overseas ask your doctor, diabetes educator/nurse for a letter explaining why you are taking injectable devices with you. You may not be able to get Lyxumia in the country that you are visiting. If you become pregnant while you are taking this medicine, stop taking it and tell your doctor or pharmacist immediately. lyxumia-ccdsv1-cmiv2-13mar14 Page 3

Things you must not do Do not use Lyxumia more often than recommended by your doctor. Do not use this medicine to treat any other complaints unless your doctor tells you to. Do not stop using Lyxumia without checking with your doctor. If you stop using Lyxumia, your blood sugar levels can increase. Do not give this medicine to anyone else, even if they have the same condition as you. Things to be careful of Tell your doctor if you drink alcohol. Alcohol may mask the symptoms of low blood sugar levels (hypoglycaemia) or make it worse. Be careful driving or operating machinery. If you use Lyxumia in combination with a sulfonylurea and a basal insulin, you may get low blood sugar (hypoglycaemia). This may cause dizziness or reduce your ability to concentrate. Side Effects All medicines have some unwanted side effects. Sometimes they are serious, but most of the time they are not. Your doctor has weighed the risks of using this medicine against the benefits they expect it will have for you. Do not be alarmed by this list of possible side effects. You may not experience any of them. Tell your doctor or pharmacist as soon as possible if you do not feel well while you are using Lyxumia helps most people with type 2 diabetes to reduce their blood glucose levels, but it may have unwanted side effects in a few people. When Lyxumia is used in combination with a sulfonylurea and a basal insulin, your risk of low blood sugar levels (hypoglycaemia) can increase. Your doctor may reduce the dose of these medicines if this happens. The first symptoms of mild to moderate hypoglycaemia can come on suddenly. They may include: cold sweat, cool pale skin fatigue, drowsiness, unusual tiredness and weakness nervousness, anxious feeling tremor, rapid heart beat confusion, difficulty concentrating excessive hunger vision changes headache, nausea If you are experiencing any of these symptoms of hypoglycaemia, immediately eat some sugary food or have a drink, e.g. lollies, biscuits or fruit juice. Then immediately go to Accident and Emergency at your nearest hospital, and tell them that you think you are having a hypo. Tell your doctor if you have trouble recognising the symptoms of hypoglycaemia. Under certain conditions, the early warning signs of hypoglycaemia can be different or less obvious. you notice any of the following and they worry you: nausea (feeling sick) vomiting (being sick) diarrhoea dizziness or light headedness redness, swelling or itching at the site of the injection site These are the more common side effects of These side effects are mostly mild and usually go away over time. If any of the following happen, stop taking this medicine and tell your doctor immediately, or go to Accident and Emergency at your nearest hospital: swelling of the face, lips, mouth or throat, which may cause difficulty in swallowing or breathing hives or itchy pinkish swellings on the skin feeling faint passing of little or no urine drowsiness any severe skin reaction severe abdominal pain which may also be accompanied by diarrhoea and/or nausea and/or vomiting These are very serious side effects. If you have them, you may have had a serious reaction to You may need urgent medical attention or hospitalisation. These side effects are very rare. you notice anything else that is making you feel unwell. Other side effects not listed above may occur in some patients. Do not be alarmed by this list of possible side effects. You may not experience any of them. Ask your doctor or pharmacist to answer any questions you may have. lyxumia-ccdsv1-cmiv2-13mar14 Page 4

After Using Lyxumia Storage Keep your Lyxumia pen in the carton until it is time to use it. Keep the cap on your Lyxumia pen until you need to use it. The ingredients in Lyxumia may not work as well if exposed to light for long periods. Before first Use Lyxumia must be stored refrigerated between 2 C and 8 C in the outer packaging in order to protect it from light. Keep it away from the freezer compartment. During use of the pen The pen can be used for 14 days. Lyxumia can be kept out of the refrigerator at a temperature not exceeding 30 C. Do not refrigerate or freeze it after first use. The pen cap should be replaced on the pen after each use to protect it from light. The pen should not be stored with a needle attached. Do not use if frozen. Keep the medicine in a cool dry place where the temperature stays below 30 C. Do not store it or any other medicine in the bathroom or near a sink. Do not leave it in the car on hot days or on window sills. Heat and dampness and light can destroy some medicines. Keep it where children cannot reach it. Disposal If your doctor or pharmacist tells you to stop using Lyxumia or the medicine has passed its expiry date, ask your pharmacist what to do with any that are left over. Return any unused medicine to your Product Description What it looks like Lyxumia is a clear and colourless solution for injection filled in a glass cartridge that is inserted in a pre-filled pen. Lyxumia comes in two strengths 10 microgram and 20 micrograms. Each green coloured Lyxumia pen contains 3 ml of solution, delivering 14 doses of 10 micrograms for Lyxumia 10 mcg. Each purple coloured Lyxumia pen contains 3 ml of solution, delivering 14 doses of 20 micrograms for Lyxumia 20 mcg. Lyxumia is available in packs containing 1 pen for Lyxumia 10 micrograms and in packs containing 1, 2 or 6 pens for Lyxumia 20 micrograms. For treatment initiation, Lyxumia is available in a pack containing one pen for Lyxumia 10 micrograms and one pen for Lyxumia 20 micrograms. Not all pack sizes may be marketed. Ingredients Active Ingredient: Each 0.2 ml dose contains either 10 micrograms or 20 micrograms of the active ingredient, lixisenatide Inactive Ingredients: glycerol (85%) sodium acetate methionine meta-cresol hydrochloric acid sodium hydroxide water for injections Lyxumia does not contain sucrose, gluten, tartrazine or any other azo dyes. Lyxumia contains less than 1 mmol sodium (23mg) per dose i.e essentially sodium free Manufacturer/Sponsor Lyxumia is supplied in Australia by: sanofi-aventis australia pty ltd 12-24 Talavera Road Macquarie Park NSW 2113 Lyxumia is supplied in New Zealand by: Sanofi-aventis new zealand limited Level 8, James and Wells Tower 56 Cawley Street Ellerslie Auckland Australian Registration Number(s): Lyxumia 10 microgram AUST R 192722 Lyxumia 20 microgram Aust R 192719 Lyxumia Treatment Initiation Pack - Aust R 192721 This leaflet was prepared in February 2013 lyxumia-ccdsv1-cmiv2-13mar14 Page 5